Prestige Consumer [PBH] vs Amneal [AMRX] Detailed Stock Comparison

Prestige Consumer Healthcare Inc.

NYSE
Loading...

Amneal Pharmaceuticals Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Prestige Consumer Healthcare Inc. wins in 13 metrics, Amneal Pharmaceuticals Inc. wins in 7 metrics, with 0 ties. Prestige Consumer Healthcare Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Prestige Consumer Healthcare Inc. Amneal Pharmaceuticals Inc. Better
P/E Ratio (TTM) 15.18 63.23 Prestige Consumer Healthcare Inc.
Price-to-Book Ratio 1.49 -57.42 Prestige Consumer Healthcare Inc.
Debt-to-Equity Ratio 59.00 45,095.52 Prestige Consumer Healthcare Inc.
PEG Ratio -0.75 -0.30 Amneal Pharmaceuticals Inc.
EV/EBITDA 10.24 10.64 Prestige Consumer Healthcare Inc.
Profit Margin (TTM) 16.90% 2.39% Prestige Consumer Healthcare Inc.
Operating Margin (TTM) 29.10% 14.06% Prestige Consumer Healthcare Inc.
EBITDA Margin (TTM) 29.10% 14.06% Prestige Consumer Healthcare Inc.
Return on Equity 10.31% -101.02% Prestige Consumer Healthcare Inc.
Return on Assets (TTM) 6.13% 7.32% Amneal Pharmaceuticals Inc.
Free Cash Flow (TTM) $243.29M $225.64M Prestige Consumer Healthcare Inc.
1-Year Return -44.52% 79.92% Amneal Pharmaceuticals Inc.
Price-to-Sales Ratio (TTM) 2.51 1.47 Amneal Pharmaceuticals Inc.
Enterprise Value $3.74B $6.86B Amneal Pharmaceuticals Inc.
EV/Revenue Ratio 3.39 2.27 Amneal Pharmaceuticals Inc.
Gross Profit Margin (TTM) 55.52% 36.50% Prestige Consumer Healthcare Inc.
Revenue per Share (TTM) $23 $10 Prestige Consumer Healthcare Inc.
Earnings per Share (Diluted) $3.79 $0.22 Prestige Consumer Healthcare Inc.
Beta (Stock Volatility) 0.47 1.32 Prestige Consumer Healthcare Inc.
Short % of Float 8.04% 3.47% Amneal Pharmaceuticals Inc.

Prestige Consumer Healthcare Inc. vs Amneal Pharmaceuticals Inc. Stock Performance Analysis

Loading Price Chart...

PBH
AMRX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Prestige Consumer Healthcare Inc.-0.85%-4.56%-17.14%-33.12%-23.22%-25.14%
Amneal Pharmaceuticals Inc.1.82%-1.09%-3.51%-8.13%5.42%-0.08%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Prestige Consumer Healthcare Inc.-44.52%-18.75%-4.94%-11.39%281.46%345.87%
Amneal Pharmaceuticals Inc.79.92%416.47%141.21%-10.41%-10.41%-10.41%

Performance & Financial Health Analysis: Prestige Consumer Healthcare Inc. vs Amneal Pharmaceuticals Inc.

MetricPBHAMRX
Market Information
Market Cap i$2.78B$4.15B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i403,6771,402,990
90 Day Avg. Volume i517,8761,913,723
Last Close$45.44$12.88
52 Week Range$42.62 - $87.12$7.07 - $15.42
% from 52W High-47.84%-16.47%
All-Time High$90.04 (Mar 10, 2025)$24.48 (Aug 20, 2018)
% from All-Time High-49.53%-47.39%
Growth Metrics
Quarterly Revenue Growth-0.02%0.12%
Quarterly Earnings Growth-0.24%0.11%
Financial Health
Profit Margin (TTM) i0.17%0.02%
Operating Margin (TTM) i0.29%0.14%
Return on Equity (TTM) i0.10%-1.01%
Debt to Equity (MRQ) i59.0045,095.52
Cash & Liquidity
Book Value per Share (MRQ)$38.66$-0.23
Cash per Share (MRQ)$1.32$0.91
Operating Cash Flow (TTM) i$276.63M$339.99M
Levered Free Cash Flow (TTM) i$207.17M$197.07M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Prestige Consumer Healthcare Inc. vs Amneal Pharmaceuticals Inc.

MetricPBH (Apr 24, 2026)AMRX (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i15.1863.23
Forward P/E i11.9611.78
PEG Ratio i-0.75-0.30
Price to Sales (TTM) i2.511.47
Price to Book (MRQ) i1.49-57.42
Market Capitalization
Market Capitalization i$2.78B$4.15B
Enterprise Value i$3.74B$6.86B
Enterprise Value Metrics
Enterprise to Revenue i3.392.27
Enterprise to EBITDA i10.2410.64
Risk & Other Metrics
Beta i0.471.32
Book Value per Share (MRQ) i$38.66$-0.23

Financial Statements Comparison: Prestige Consumer Healthcare Inc. vs Amneal Pharmaceuticals Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPBH (2025)AMRX (2025)
Revenue/Sales i1.14B3.02B
Cost of Goods Sold i503.30M1.91B
COGS % of Revenue i44.2%63.1%
Gross Profit i634.46M1.11B
Gross Margin i55.8%36.9%
Research & Development iN/A193.81M
Operating Income (EBIT) i349.24M397.91M
Operating Margin i30.7%13.2%
EBITDA i374.46M606.64M
EBITDA Margin i32.9%20.1%
Pre-Tax Income i284.19M139.21M
Pre-Tax Income % of Revenue i25.0%4.6%
Income Tax i69.58M11.28M
Income Tax % of Revenue i6.1%0.4%
Net Income (Profit) i214.61M127.93M
Profit Margin i18.9%4.2%

Balance Sheet & Liquidity Metrics

MetricPBH (2025)AMRX (2025)
Cash & Equivalents i97.88M282.03M
Total Current Assets i448.33M1.91B
Total Current Assets % of Revenue i39.4%63.3%
Total Current Liabilities i106.62M881.63M
Total Current Liabilities % of Revenue i9.4%29.2%
Long-Term Debt i1.04B2.67B
Long-Term Debt % of Revenue i91.0%88.4%
Total Shareholders Equity i1.83B-71.33M
Retained Earnings i1.56B-535.01M
Retained Earnings % of Revenue i136.7%-17.7%
Property, Plant & Equipment i53.29M107.38M

Cash Flow Statement Comparison

MetricPBH (2025)AMRX (2025)
Operating Cash Flow i227.18M256.93M
Operating Cash Flow % of Revenue i20.0%8.5%
Capital Expenditures i-8.22M-96.75M
Free Cash Flow i243.29M225.64M
FCF Margin i21.4%7.5%
Debt Repayment i-139.54M-2.81B
Common Stock Repurchase i-51.51MN/A

Short Interest & Institutional Ownership Analysis

MetricPBHAMRX
Shares Short i2.69M7.19M
Short Ratio i5.783.18
Short % of Float i8.04%3.47%
Shares Outstanding i47.32M314.57M
Float Shares i46.75M176.28M
% Held by Insiders i1.30%44.04%
% Held by Institutions i111.41%49.74%
% Held by Public i-12.71%6.22%

Dividend Analysis & Yield Comparison: Prestige Consumer Healthcare Inc. vs Amneal Pharmaceuticals Inc.

MetricPBHAMRX
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i$0.00N/A
Ex-Dividend DateN/AN/A